|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pharmacokinetics of CS-866,a new angiotensin Ⅱ receptor blocker,in healthy subjects显示文摘 | Schwocho LR Masonson HN | 2001 | J Clin Pharmacol2001，41，5： | 1 |
| 2 | Pharmacokinetics of CS-866, a new angiotensin Ⅱ receptor blocker, in healthy subjects显示文摘 | Sehwocho LR Masonson HN | 2001 | J Clin Pharmacol2001，41，5： | 1 |
| 3 | Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials 显示文摘 | D' Amico DJ Masonson HN Patel M Adamis AP Cunningham ET Jr Guyer DR VEGF Inhibition Study in Ocular Neovascularization (VISION)Clhfical Trial Group | 2006 | Ophthalmology2006，113，6： | 1 |
| 4 | Pharmacokinetics of CS-866, a new angiotension Ⅱ receptor blocker,in health subjects 显示文摘 | Schwocho LR Masonson HN | 2001 | J Clin Pharmacol2001，41，5： | 1 |
| 5 | Pharmacokinetics of CS-866,a new angiotensin Ⅱ receptor blocker,in healthy subjects显示文摘 | SCHWOCHO LR MASONSON HN | 2001 | Clin Pharmacol2001，41，5： | 1 |
| 6 | Pharmacokinetics of CS-866, a new angiotensin Ⅱ receptor blocker, in health subjects显示文摘 | SCHWOCHO LR MASONSON HN | 2001 | J Clin Pharmacol2001，41，5： | 1 |
| 7 | Pharmacokinetics of CS- 866,a new angiotensin I1 receptor blocker,in healthy subjects显示文摘 | Schwocho LR Masonson HN | 2001 | J Clin Pharmacol2001，41，5： | 1 |
| 8 | Pegaptanib sodium for neovascular age-related macular degeneration: Two-year safety results of the two prospective, multicenter, controlled clinical trials显示文摘 | D'Amico DJ Masonson HN Patel M | 2006 | Ophthalmology2006，113，6： | 1 |
| 9 | Pegaptanib sodium for neovascular age-related macular degeneration-Two-year safety results of the two prospective, multicenter, controlled clinical trials显示文摘 | D'AMICO DJ MASONSON HN PATEL M | 2006 | Ophthalmology2006，113，6： | 1 |
| 10 | Pharmacokinetics of CS - 866, a new angiotensin Ⅱ receptor blocker, in healthy subjects 显示文摘 | Schwocho LR Masonson HN | 2001 | J Clin Pharmacol2001，41，： | 1 |
| 11 | Pegaptanib sodium for neovascular age-related macular degeneration : two-year safety results of the two prospective, multicenter, controlled clini- cal trials 显示文摘 | D'AMICO DJ MASONSON HN PATEL M | 2006 | Ophthalmology2006，113，6： | 1 |
| 12 | Pharmacokinetics of CS - 866, a new angiotensin Ⅱ receptor blocker, in healthy subjects显示文摘 | Schwocho LR Masonson HN | 2001 | J Clin Pharmacol2001，41，5： | 1 |
| 13 | Pegaptanib sodium for neovascular age-related macular degeneration:two- year safety results of the two prospective, multicenter, controlled clinical trials显示文摘 | D' Amico DJ Masonson HN Patel M | 2006 | Ophthalmology2006，113，6： | 1 |
| 14 | Pharmacokinetics of CS-866,a new angiotensin II receptor blocker,in healthy subjects显示文摘 | Schwocho LR Masonson HN | 2009 | J Clin Pharmacol2009，41，： | 1 |
| 15 | Pegaptanib sodium for neovascular age-related macular degeneration:two-year safety results of the two prospective,multicenter,controlled clinical trials显示文摘 | D'Amico DJ Masonson HN Patel M | 2006 | Ophthalmology2006，113，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员